Advanced search for available technology

  Username(email)             Password
  (Same as The Knowledge Vine if you are a Vine user)This service is provided free by UMIP^®

          

Latest IP offers

A new generation of small peptides (6-12mers) with potent in vitro and in vivo activity against influenza A viruses     |       Fuel cell technology that converts Urine / Urea / Ammonia to energy and clean water - low cost viable alternative to H2     |       A method of assessing efficiency of internal combustion engines      |       Software for viewwing, manipulating and interpreting LiDAR (ground penetrating radar) data      |       A s/w programmable CMOS chip in which an image processor is integrated within each pixel of the image sensor     |

Latest Tech Requests

Reduction of sodium andamp; saturated fats in foodstuffs     |       Increased sound absorption for nonwoven materials     |       Prevention of flavour volatile loss during cooking     |       Do you use Yet2, Ninesigma or Innocentive? Why?     |       Post your tech requests on IP Net for free     |

Overview       Browse IP offers       Browse tech requests       Advanced Search       Testimonials       FAQs       Encouraging open innovation       What makes this different?       Our Sponsors & Partners

Email this IP record To email address From email address Email subject Email message IP Net technology offering #IP0000871 Title Micro-RNAs for treatment of viral infections What the technology is A family of micro-ribonucleic acids (miRNAs) that have broad acting anti-viral function on DNA and RNA viruses. What it does A number of miRNAs have been identified that can modulate host cell defence mechanisms to prevent viral replication and limit the spread of infection. Furthermore, the miRNAs have been shown to have broad acting anti-viral activity on diverse viral families, such as Influenza, Herpes and Togaviruses Possible applications RNA therapeutics; Anti-viral therapies to treat a broad range of infections, including Influenza Perceived UNIQUE ADVANTAGES New approach to antivirals overcoming current problems with resistance; Broad spectrum anti-viral miRNAs; Naturally modulates the host innate immunity; Due to their small size, miRNAs can enter the cell undetected Further Information such as stage of development This technology is subject to a UK priority application. The University of Edinburgh is seeking industrial partners to help commercialise this technology via a licensing and collaborative research agreement. Link to further info Organisation marketing this The University of Edinburgh Country Location United Kingdom Reference number 2141 Contact name Alex Proudfoot Contact phone number Search the IP Net database   Advanced search View other IP Net Technologies that may have synergy with this Send a message to this IP provider Message Your name Your organisation Your email address